136 related articles for article (PubMed ID: 28118074)
1. GPER Promoter Methylation Controls GPER Expression in Breast Cancer Patients.
Weissenborn C; Ignatov T; Nass N; Kalinski T; Dan Costa S; Zenclussen AC; Ignatov A
Cancer Invest; 2017 Feb; 35(2):100-107. PubMed ID: 28118074
[TBL] [Abstract][Full Text] [Related]
2. GPER functions as a tumor suppressor in triple-negative breast cancer cells.
Weißenborn C; Ignatov T; Ochel HJ; Costa SD; Zenclussen AC; Ignatova Z; Ignatov A
J Cancer Res Clin Oncol; 2014 May; 140(5):713-23. PubMed ID: 24553912
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of G Protein-Coupled Estrogen Receptor (GPER) is Associated with Reduced Prognosis in Patients with Gastric Cancer.
Tian S; Zhan N; Li R; Dong W
Med Sci Monit; 2019 Apr; 25():3115-3126. PubMed ID: 31028714
[TBL] [Abstract][Full Text] [Related]
4. Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells.
Rigiracciolo DC; Santolla MF; Lappano R; Vivacqua A; Cirillo F; Galli GR; Talia M; Muglia L; Pellegrino M; Nohata N; Di Martino MT; Maggiolini M
J Exp Clin Cancer Res; 2019 Feb; 38(1):58. PubMed ID: 30728047
[TBL] [Abstract][Full Text] [Related]
5. GPER-1 expression decreases during breast cancer tumorigenesis.
Ignatov T; Weißenborn C; Poehlmann A; Lemke A; Semczuk A; Roessner A; Costa SD; Kalinski T; Ignatov A
Cancer Invest; 2013 Jun; 31(5):309-15. PubMed ID: 23688258
[TBL] [Abstract][Full Text] [Related]
6. G-protein-coupled estrogen receptor GPER-1 expression in hormone receptor-positive breast cancer is associated with poor benefit of tamoxifen.
Ignatov T; Claus M; Nass N; Haybaeck J; Seifert B; Kalinski T; Ortmann O; Ignatov A
Breast Cancer Res Treat; 2019 Feb; 174(1):121-127. PubMed ID: 30478785
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation in the upstream CpG island of the GPER locus and its relationship with GPER expression in colon cancer cell lines.
Pal U; Ghosh S; Limaye AM
Mol Biol Rep; 2020 Oct; 47(10):7547-7555. PubMed ID: 32936384
[TBL] [Abstract][Full Text] [Related]
8. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
[TBL] [Abstract][Full Text] [Related]
9. Lack of G protein-coupled estrogen receptor (GPER) in the plasma membrane is associated with excellent long-term prognosis in breast cancer.
Sjöström M; Hartman L; Grabau D; Fornander T; Malmström P; Nordenskjöld B; Sgroi DC; Skoog L; Stål O; Leeb-Lundberg LM; Fernö M
Breast Cancer Res Treat; 2014 May; 145(1):61-71. PubMed ID: 24715381
[TBL] [Abstract][Full Text] [Related]
10. Estrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER.
Zekas E; Prossnitz ER
BMC Cancer; 2015 Oct; 15():702. PubMed ID: 26470790
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic Inactivation of BRCA1 Through Promoter Hypermethylation and Its Clinical Importance in Triple-Negative Breast Cancer.
Yamashita N; Tokunaga E; Kitao H; Hitchins M; Inoue Y; Tanaka K; Hisamatsu Y; Taketani K; Akiyoshi S; Okada S; Oda Y; Saeki H; Oki E; Maehara Y
Clin Breast Cancer; 2015 Dec; 15(6):498-504. PubMed ID: 26195437
[TBL] [Abstract][Full Text] [Related]
12. G-Protein Coupled Estrogen Receptor in Breast Cancer.
Hsu LH; Chu NM; Lin YF; Kao SH
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30646517
[TBL] [Abstract][Full Text] [Related]
13. GPER functions as a tumor suppressor in MCF-7 and SK-BR-3 breast cancer cells.
Weißenborn C; Ignatov T; Poehlmann A; Wege AK; Costa SD; Zenclussen AC; Ignatov A
J Cancer Res Clin Oncol; 2014 Apr; 140(4):663-71. PubMed ID: 24515910
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth.
Catalano S; Giordano C; Panza S; Chemi F; Bonofiglio D; Lanzino M; Rizza P; Romeo F; Fuqua SA; Maggiolini M; Andò S; Barone I
Breast Cancer Res Treat; 2014 Jul; 146(2):273-85. PubMed ID: 24928526
[TBL] [Abstract][Full Text] [Related]
15. NHERF1 inhibits proliferation of triple-negative breast cancer cells by suppressing GPER signaling.
Wang Y; Peng Z; Meng R; Tao T; Wang Q; Zhao C; Liu H; Song R; Zheng J; Qin Q; He J
Oncol Rep; 2017 Jul; 38(1):221-228. PubMed ID: 28535016
[TBL] [Abstract][Full Text] [Related]
16. GPER mediated estradiol reduces miR-148a to promote HLA-G expression in breast cancer.
Tao S; He H; Chen Q; Yue W
Biochem Biophys Res Commun; 2014 Aug; 451(1):74-8. PubMed ID: 25063027
[TBL] [Abstract][Full Text] [Related]
17. GPER negatively regulates TNFα-induced IL-6 production in human breast cancer cells via NF-κB pathway.
Okamoto M; Mizukami Y
Endocr J; 2016 May; 63(5):485-93. PubMed ID: 26888479
[TBL] [Abstract][Full Text] [Related]
18. Zinc finger protein 32 promotes breast cancer stem cell-like properties through directly promoting GPER transcription.
Li Y; Gong D; Zhang L; Li H; Zhang S; Zhang J; Li K; Zheng Q; Zhao G; Zhang Y; Chen Y; Guo Y; Xiang R; Lin P; Wei Y
Cell Death Dis; 2018 Nov; 9(12):1162. PubMed ID: 30478301
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer.
Liu Q; Chen Z; Jiang G; Zhou Y; Yang X; Huang H; Liu H; Du J; Wang H
Mol Cancer; 2017 May; 16(1):87. PubMed ID: 28476123
[TBL] [Abstract][Full Text] [Related]
20. SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.
Santolla MF; Avino S; Pellegrino M; De Francesco EM; De Marco P; Lappano R; Vivacqua A; Cirillo F; Rigiracciolo DC; Scarpelli A; Abonante S; Maggiolini M
Cell Death Dis; 2015 Jul; 6(7):e1834. PubMed ID: 26225773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
